EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Impella and Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating Acute Myocardial Infarction

Margriet Bogerd, Sanne Ten Berg, Elma J Peters, Alexander P J Vlaar, Annemarie E Engström, Luuk C Otterspoor, Christian Jung, Dirk Westermann, Janine Pöss, Holger Thiele, Benedikt Schrage, José P S Henriques

European Journal of Heart Failure · 2023

DOI: 10.1002/ejhf.3025 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Heart Failure, 2023. Verfasst von Margriet Bogerd und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Heart Failure, Heart-Assist Devices, Myocardial Infarction. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to give contemporary insight into the use of Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in acute myocardial infarction-related cardiogenic shock (AMICS) and into associated outcomes, adverse events, and resource demands. Methods and results This nationwide observational cohort study describes all AMICS patients treated with Impella (ABIOMED, Danvers, MA, USA) and/or VA-ECMO in 2020–2021. Impella and/or VA-ECMO were used in 20% of all AMICS cases (n = 4088). Impella patients were older (34% vs. 13% >75 years, p < 0.001) and less frequently presented after an out-of-hospital cardiac arrest (18% vs. 40%, p < 0.001). In-hospital mortality was lower in the Impella versus VA-ECMO cohort (61% vs. 67%, p = 0.001). Adverse events occurred less frequently in Impella-supported patients: acute haemorrhagic anaemia (36% vs. 68%, p < 0.001), cerebrovascular accidents (4% vs. 11%, p < 0.001), thromboembolisms of the extremities (5% vs. 8%, p < 0.001), systemic inflammatory response syndrome (21% vs. 25%, p = 0.004), acute kidney injury (44% vs. 53%, p < 0.001), and acute liver failure (7% vs. 12%, p < 0.001). Impella patients were discharged home directly more often (20% vs. 11%, p < 0.001) whereas VA-ECMO patients were more often discharged to another care facility (22% vs. 19%, p = 0.031). Impella patients had shorter hospital stays and lower hospital costs.

Conclusion

This is the largest, most recent European cohort study describing outcomes, adverse events, and resource demands based on claims data in patients with Impella and/or VA-ECMO. Overall, adverse event rates and resource consumption were high. Given the current lack of beneficial evidence, our study reinforces the need for prospectively established, high-quality evidence to guide clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationHeart FailureHeart-Assist DevicesMyocardial InfarctionHumansShock, CardiogenicCohort StudiesRetrospective Studies

Stichwörter der Autor:innen

Acute myocardial infarctionAdverse eventsCardiogenic shockImpellaResource demandsVenoarterial extracorporeal membrane oxygenation

Autor:innen und Institutionen

  • Department of Cardiology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Department of Intensive Care, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Cardiology and Department of Intensive Care Medicine, Catharina Hospital, Eindhoven, The Netherlands.
  • Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Department of Cardiology and Angiology, University Heart Centre, University Freiburg, Freiburg, Germany.
  • Department of Internal Medicine/Cardiology, Heart Centre Leipzig at the University of Leipzig and Leipzig Heart Science, Leipzig, Germany.

Zitieren

APA

Bogerd, M., Ten Berg, S., Peters, E. J., Vlaar, A. P. J., Engström, A. E., Otterspoor, L. C., Jung, C., Westermann, D., Pöss, J., Thiele, H., Schrage, B., & Henriques, J. P. S. (2023). Impella and Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating Acute Myocardial Infarction. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3025

Vancouver

Bogerd M, Ten Berg S, Peters EJ, Vlaar APJ, Engström AE, Otterspoor LC, et al. Impella and Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating Acute Myocardial Infarction. European Journal of Heart Failure. 2023. doi:10.1002/ejhf.3025

BibTeX
@article{Bogerd2023,
  author = {Bogerd, Margriet and Ten Berg, Sanne and Peters, Elma J and Vlaar, Alexander P J and Engström, Annemarie E and Otterspoor, Luuk C and Jung, Christian and Westermann, Dirk and Pöss, Janine and Thiele, Holger and Schrage, Benedikt and Henriques, José P S},
  title = {Impella and Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating Acute Myocardial Infarction},
  journal = {European Journal of Heart Failure},
  year = {2023},
  doi = {10.1002/ejhf.3025}
}
Kostenlos starten →